Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
2 days ago
2 days ago
touchIN CONVERSATION for touchONCOLOGY
Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of metastatic breast cancer, tackling questions submitted by the oncology community. They discuss how treatment can be guided by biomarkers, give practical insights into creating a personalized care plan for patients, and share strategies for managing ADC-associated toxicities.
The experts
- Prof. Giuseppe Curigliano, European Institute of Oncology and University of Milan, Italy
- Dr Alison Conlin, Providence Cancer Institute, Portland, OR, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchoncologyime.org/
No comments yet. Be the first to say something!